Cargando…

TAS2R38 is a novel modifier gene in patients with cystic fibrosis

The clinical manifestation of cystic fibrosis (CF) is heterogeneous also in patients with the same cystic fibrosis transmembrane regulator (CFTR) genotype and in affected sibling pairs. Other genes, inherited independently of CFTR, may modulate the clinical manifestation and complications of patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castaldo, Alice, Cernera, Gustavo, Iacotucci, Paola, Cimbalo, Chiara, Gelzo, Monica, Comegna, Marika, Di Lullo, Antonella Miriam, Tosco, Antonella, Carnovale, Vincenzo, Raia, Valeria, Amato, Felice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118092/ https://www.ncbi.nlm.nih.gov/pubmed/32242045 http://dx.doi.org/10.1038/s41598-020-62747-9

Ejemplares similares

Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis
por: Gelzo, Monica, et al.
Publicado: (2020)

Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers
por: Esposito, Maria Valeria, et al.
Publicado: (2020)

Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study
por: Amato, Felice, et al.
Publicado: (2021)

Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis
por: Polito, Rita, et al.
Publicado: (2019)

Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment
por: Carnovale, Vincenzo, et al.
Publicado: (2022)

Lipidomic alterations in human saliva from cystic fibrosis patients
por: Caterino, Marianna, et al.
Publicado: (2023)

Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles
por: Comegna, Marika, et al.
Publicado: (2021)

Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021)

Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study
por: Maglione, Marco, et al.
Publicado: (2017)

Prenatal Diagnosis of Cystic Fibrosis and Hemophilia: Incidental Findings and Weak Points
por: Comegna, Marika, et al.
Publicado: (2019)

Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization
por: Cernera, Gustavo, et al.
Publicado: (2020)

Cystic Fibrosis-Screening Positive Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up Permits to Early Identify Patients with CFTR-Related Disorders
por: Castaldo, Alice, et al.
Publicado: (2020)

Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis
por: Tosco, Antonella, et al.
Publicado: (2021)

Pseudo‐Bartter syndrome in infant with cystic fibrosis screen positive, inconclusive diagnosis: A case report
por: Sepe, Angela, et al.
Publicado: (2023)

Elevated sweat chloride test: is it always cystic fibrosis?
por: Cimbalo, C., et al.
Publicado: (2021)

Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules
por: Carnovale, Vincenzo, et al.
Publicado: (2022)

S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy
por: Terlizzi, Vito, et al.
Publicado: (2018)

NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders
por: Esposito, Maria Valeria, et al.
Publicado: (2021)

Molecular Analysis of Prothrombotic Gene Variants in Patients with Acute Ischemic Stroke and with Transient Ischemic Attack
por: Cernera, Gustavo, et al.
Publicado: (2021)

Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients
por: Nigro, Ersilia, et al.
Publicado: (2021)

Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine
por: Rosanio, Francesco Maria, et al.
Publicado: (2021)

An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis
por: Di Lullo, A.M., et al.
Publicado: (2017)

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease
por: Maiuri, Luigi, et al.
Publicado: (2019)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study
por: Gelzo, Monica, et al.
Publicado: (2021)

Clinical expression of cystic fibrosis in a large cohort of Italian siblings
por: Terlizzi, Vito, et al.
Publicado: (2018)

Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis
por: Piona, Claudia, et al.
Publicado: (2022)

Employment Status and Work Ability in Adults with Cystic Fibrosis
por: Leso, Veruscka, et al.
Publicado: (2021)

Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2006)

Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
por: Volpi, Sonia, et al.
Publicado: (2022)

Further Findings Concerning Endothelial Damage in COVID-19 Patients
por: Gelzo, Monica, et al.
Publicado: (2021)

Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
por: Gelzo, Monica, et al.
Publicado: (2022)

Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis
por: Villella, Valeria R., et al.
Publicado: (2019)

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease
por: Terlizzi, Vito, et al.
Publicado: (2021)

Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?
por: Gelzo, Monica, et al.
Publicado: (2022)

Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis
por: Sofia, Valentina Maria, et al.
Publicado: (2018)

WS14.3 Virtual consultation in cystic fibrosis: an Italian experience
por: Carnovale, V., et al.
Publicado: (2021)

The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis
por: Occhigrossi, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mpjt5j3fifodgthqvn1k7kep3d